NIAID supports research to address the disproportionate public health burden of asthma in inner-city populations. NIAID-funded research focuses on understanding how the environment, allergens, and genetics interact with the body’s immune system to cause asthma and aggravate its symptoms.
The following clinical studies are ongoing, but not recruiting participants:
Asthma Phenotypes in the Inner-City (ClinicalTrials.gov identifier NCT01383941)
The purpose of this research study is to look at traits or characteristics of people with asthma. Researchers want to learn why some people with asthma need to take a lot more medication than other people with the disease.
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ClinicalTrials.gov identifier NCT01430403)
The purpose of this research study is to look at three asthma treatments and their ability to reduce fall asthma attacks in children. Researchers want to learn if different types of study medications will prevent an asthma attack during the fall season better than standard asthma care.
Read more about NIAID’s role in asthma research.
Visit the National Heart, Lung and Blood Institute website to learn about the importance of children in clinical studies.
Last Updated December 11, 2013
Last Reviewed March 11, 2013